Sartorius AG
OTC:SARTF

Watchlist Manager
Sartorius AG Logo
Sartorius AG
OTC:SARTF
Watchlist
Price: 225 USD Market Closed
Market Cap: $15.5B

Operating Margin

14.1%
Current
Declining
by 2.3%
vs 3-y average of 16.3%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
14.1%
=
Operating Income
€494.4m
/
Revenue
€3.5B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
14.1%
=
Operating Income
$494.4m
/
Revenue
€3.5B

Peer Comparison

Country Company Market Cap Operating
Margin
DE
Sartorius AG
XETRA:SRT
14B EUR
Loading...
US
Abbott Laboratories
NYSE:ABT
189.1B USD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
190.1B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
138.7B USD
Loading...
US
Stryker Corp
NYSE:SYK
136.1B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
130.6B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
58.1B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
48.5B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
56B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
48.9B USD
Loading...
US
Resmed Inc
NYSE:RMD
37.3B USD
Loading...

Market Distribution

Higher than 80% of companies in Germany
Percentile
80th
Based on 3 747 companies
80th percentile
14.1%
Low
-61 459.6% — 0.7%
Typical Range
0.7% — 9.8%
High
9.8% — 94 540%
Distribution Statistics
Germany
Min -61 459.6%
30th Percentile 0.7%
Median 4.5%
70th Percentile 9.8%
Max 94 540%

Sartorius AG
Glance View

Market Cap
15.5B USD
Industry
Health Care

Sartorius AG, a formidable player in the life sciences industry, has been weaving the fabric of innovation within the biotechnology sector for over a century. Originating in 1870 as a precision mechanics workshop in Göttingen, Germany, the company has blossomed into a global powerhouse in the biopharmaceutical and laboratory equipment market. Central to Sartorius's operations is its focus on providing cutting-edge solutions that streamline lab processes and enhance productivity. By offering essential products like bioreactors and cell culture media, Sartorius plays a pivotal role in accelerating research and production processes for pharmaceutical companies worldwide. Underpinning Sartorius's financial success is its dual-pronged strategy: the Bioprocess Solutions division and the Lab Products & Services division. The Bioprocess Solutions wing caters to the production needs of biopharmaceuticals, delivering equipment and technologies crucial for manufacturing therapies and vaccines. Meanwhile, the Lab Products & Services division offers an array of instruments and consumables pivotal for research and quality control. This strategic alignment allows Sartorius to maintain robust growth by capturing value from both research and industrial production stages in biotech. With a well-orchestrated focus on innovation and expansion, Sartorius has cemented its role as a critical enabler in the biopharmaceutical value chain, continually driving developments that shape the future of medicine.

SARTF Intrinsic Value
229.92 USD
Undervaluation 2%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
14.1%
=
Operating Income
€494.4m
/
Revenue
€3.5B
What is Sartorius AG's current Operating Margin?

The current Operating Margin for Sartorius AG is 14.1%, which is below its 3-year median of 16.3%.

How has Operating Margin changed over time?

Over the last 3 years, Sartorius AG’s Operating Margin has decreased from 27.3% to 14.1%. During this period, it reached a low of 11.8% on Mar 31, 2025 and a high of 27.3% on Sep 30, 2022.

Back to Top